Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
85.32
+2.23 (2.68%)
At close: Oct 14, 2025, 4:00 PM EDT
85.32
0.00 (0.00%)
After-hours: Oct 14, 2025, 7:00 PM EDT
Glaukos Revenue
Glaukos had revenue of $124.12M in the quarter ending June 30, 2025, with 29.71% growth. This brings the company's revenue in the last twelve months to $432.95M, up 26.70% year-over-year. In the year 2024, Glaukos had annual revenue of $383.48M with 21.85% growth.
Revenue (ttm)
$432.95M
Revenue Growth
+26.70%
P/S Ratio
11.06
Revenue / Employee
$435,129
Employees
995
Market Cap
4.89B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 383.48M | 68.77M | 21.85% |
Dec 31, 2023 | 314.71M | 31.85M | 11.26% |
Dec 31, 2022 | 282.86M | -11.15M | -3.79% |
Dec 31, 2021 | 294.01M | 69.05M | 30.70% |
Dec 31, 2020 | 224.96M | -12.03M | -5.07% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
GKOS News
- 13 hours ago - Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting - Business Wire
- 6 days ago - Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29 - Business Wire
- 19 days ago - Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama - Business Wire
- 2 months ago - Glaukos Announces Participation in Wells Fargo Healthcare Conference - Business Wire
- 2 months ago - Glaukos Corporation (GKOS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Glaukos Announces Second Quarter 2025 Financial Results - Business Wire
- 3 months ago - Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30 - Business Wire
- 3 months ago - Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies - Business Wire